424 related articles for article (PubMed ID: 37468932)
41. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
42. Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.
Maffioletti E; Valsecchi P; Minelli A; Magri C; Bonvicini C; Barlati S; Sacchetti E; Vita A; Gennarelli M
Drug Dev Res; 2020 Sep; 81(6):754-761. PubMed ID: 32462699
[TBL] [Abstract][Full Text] [Related]
43. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
Sikich L; Frazier JA; McClellan J; Findling RL; Vitiello B; Ritz L; Ambler D; Puglia M; Maloney AE; Michael E; De Jong S; Slifka K; Noyes N; Hlastala S; Pierson L; McNamara NK; Delporto-Bedoya D; Anderson R; Hamer RM; Lieberman JA
Am J Psychiatry; 2008 Nov; 165(11):1420-31. PubMed ID: 18794207
[TBL] [Abstract][Full Text] [Related]
44. International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia.
Jeste DV; Barak Y; Madhusoodanan S; Grossman F; Gharabawi G
Am J Geriatr Psychiatry; 2003; 11(6):638-47. PubMed ID: 14609804
[TBL] [Abstract][Full Text] [Related]
45. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia.
Kinon BJ; Chen L; Ascher-Svanum H; Stauffer VL; Kollack-Walker S; Zhou W; Kapur S; Kane JM
Neuropsychopharmacology; 2010 Jan; 35(2):581-90. PubMed ID: 19890258
[TBL] [Abstract][Full Text] [Related]
46. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study.
Liang Y; Yu X
Neuropsychiatr Dis Treat; 2017; 13():1163-1173. PubMed ID: 28461752
[TBL] [Abstract][Full Text] [Related]
47. Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.
Hwang TJ; Lee SM; Sun HJ; Lin HN; Tsai SJ; Lee YC; Chen YS
J Formos Med Assoc; 2003 Jan; 102(1):30-6. PubMed ID: 12684609
[TBL] [Abstract][Full Text] [Related]
48. Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia.
Liu-Seifert H; Osuntokun OO; Feldman PD
Compr Psychiatry; 2012 Jan; 53(1):107-15. PubMed ID: 21310400
[TBL] [Abstract][Full Text] [Related]
49. Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
Stauffer V; Ascher-Svanum H; Liu L; Ball T; Conley R
BMC Psychiatry; 2009 Mar; 9():13. PubMed ID: 19335905
[TBL] [Abstract][Full Text] [Related]
50. Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study.
Zhou Y; Li G; Li D; Cui H; Ning Y
J Psychopharmacol; 2018 May; 32(5):524-532. PubMed ID: 29493377
[TBL] [Abstract][Full Text] [Related]
51. Cannabis and schizophrenia.
McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
[TBL] [Abstract][Full Text] [Related]
52. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
Takahashi H; Kamata M; Yoshida K; Ishigooka J; Higuchi H
J Clin Psychiatry; 2006 Oct; 67(10):1577-82. PubMed ID: 17107250
[TBL] [Abstract][Full Text] [Related]
53. The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia.
Zhang Y; Tao S; Coid J; Wei W; Wang Q; Yue W; Yan H; Tan L; Chen Q; Yang G; Lu T; Wang L; Zhang F; Yang J; Li K; Lv L; Tan Q; Zhang H; Ma X; Yang F; Li L; Wang C; Zhao L; Deng W; Guo W; Ma X; Zhang D; Li T
Curr Neuropharmacol; 2024; 22(1):159-167. PubMed ID: 36600620
[TBL] [Abstract][Full Text] [Related]
54. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
Chen JJ; Chan HY; Chen CH; Gau SS; Hwu HG
Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
[TBL] [Abstract][Full Text] [Related]
55. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
[TBL] [Abstract][Full Text] [Related]
56. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
Gureje O; Miles W; Keks N; Grainger D; Lambert T; McGrath J; Tran P; Catts S; Fraser A; Hustig H; Andersen S; Crawford AM
Schizophr Res; 2003 Jun; 61(2-3):303-14. PubMed ID: 12729882
[TBL] [Abstract][Full Text] [Related]
57. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
[TBL] [Abstract][Full Text] [Related]
58. Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.
Taylor JH; Appel S; Eli M; Alexander-Bloch A; Maayan L; Gur RE; Bloch MH
J Child Adolesc Psychopharmacol; 2021 Feb; 31(1):46-52. PubMed ID: 32633541
[No Abstract] [Full Text] [Related]
59. Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.
Ardizzone I; Nardecchia F; Marconi A; Carratelli TI; Ferrara M
Psychopharmacol Bull; 2010; 43(2):45-66. PubMed ID: 21052042
[TBL] [Abstract][Full Text] [Related]
60. Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).
Kjelby E; Gjestad R; Fathian F; Sinkeviciute I; Alisauskiene R; Anda L; Løberg EM; Reitan SK; Joa I; Larsen TK; Rettenbacher M; Berle JØ; Fasmer OB; Kroken RA; Johnsen E
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):246-258. PubMed ID: 37083542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
